Loading
Latest filing published 18 Jul 2025 for Entera Bio Ltd.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Dana Yaacov-Garbeli discloses dealings in Entera Bio Ltd. to SEC (Form 4). Over a trading history stretching from 11 November 2022 to 16 July 2025, the count stands at 4 filings.
No open-market sale appears; the market trades are 1 purchase worth €15k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 3 share grants.
The record was last updated on 18 July 2025 with a share grant in Entera Bio Ltd. The last insider purchase was made public on 15 November 2022, 1,433 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations